While cytokines are crucial for coordinating inflammatory responses within the tumor microenvironment (TME), immunotherapies employing cytokines such as interferon (IFN)s and interleukin (IL)s, are recognized as potential cancer therapies [2]. This evidence concerns the gene IFNA1 and cancer.